These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11902549)

  • 1. Childhood acute lymphoblastic leukaemia--current status and future perspectives.
    Pui CH; Campana D; Evans WE
    Lancet Oncol; 2001 Oct; 2(10):597-607. PubMed ID: 11902549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in childhood acute lymphoblastic leukemia.
    Pui CH
    J Formos Med Assoc; 2004 Feb; 103(2):85-95. PubMed ID: 15083238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood acute lymphoblastic leukemia.
    Pui CH; Relling MV; Campana D; Evans WE
    Rev Clin Exp Hematol; 2002 Jun; 6(2):161-80; discussion 200-2. PubMed ID: 12196214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsed childhood acute lymphoblastic leukaemia.
    Bhojwani D; Pui CH
    Lancet Oncol; 2013 May; 14(6):e205-17. PubMed ID: 23639321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A brief history of treatments for childhood acute lymphoblastic leukaemia].
    Leverger G; Baruchel A; Schaison G
    Bull Acad Natl Med; 2009 Oct; 193(7):1495-9; discussion 1499-500. PubMed ID: 20669630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
    Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE;
    Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
    Izraeli S
    Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.
    Schrappe M
    Radiat Prot Dosimetry; 2008; 132(2):130-3. PubMed ID: 19017727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in acute lymphoblastic leukemia in children and adolescents: an expert panel discussion.
    Asselin BL; Gaynon P; Whitlock JA
    Curr Opin Oncol; 2013 Dec; 25 Suppl 3():S1-13; quiz S14-6. PubMed ID: 24305505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
    Cheok MH; Evans WE
    Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukaemia.
    Inaba H; Greaves M; Mullighan CG
    Lancet; 2013 Jun; 381(9881):1943-55. PubMed ID: 23523389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of childhood and adult acute lymphoblastic leukaemia.
    Liesner R; Goldstone AH
    J Intern Med Suppl; 1997; 740():29-36. PubMed ID: 9350179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis prediction for childhood acute lymphoblastic leukemia--review].
    Liu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):202-6. PubMed ID: 17490555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now.
    Goulden N; Virgo P; Grimwade D
    Br J Haematol; 2006 Aug; 134(3):273-82. PubMed ID: 16848770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.
    Rubnitz JE
    J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.
    Gandemer V; Pochon C; Oger E; Dalle JH; Michel G; Schmitt C; de Berranger E; Galambrun C; Cavé H; Cayuela JM; Grardel N; Macintyre E; Margueritte G; Méchinaud F; Rorhlich P; Lutz P; Demeocq F; Schneider P; Plantaz D; Poirée M; Bordigoni P
    Br J Haematol; 2014 May; 165(3):392-401. PubMed ID: 24479958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of childhood acute lymphoblastic leukemia.
    Brenner TL; Pui CH; Evan WE
    Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted treatment of pediatric acute lymphoblastic leukemia.
    Jeha S; Pui CH
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):973-90, v. PubMed ID: 19825448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.